EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8 + T-cell antitumor activity via the non-canonical P53/STING pathway

Jie Wu, Nian Liu, Jing Chen, Qian Tao, Can Lu, Qiuqiu Li, Xiang Chen, Cong Peng

Journal for ImmunoTherapy of Cancer · 2025

DOI: 10.1136/jitc-2024-010252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2025. Verfasst von Jie Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Tumor Suppressor Protein p53, Pyroptosis, Membrane Proteins. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Hunan Province, 111 Project, National Natural Science Foundation of China, Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clofarabine (Clo) is a Food and Drug Administration (FDA)-approved drug for the treatment of acute lymphoblastic leukemia; however, its effects on solid tumors remain largely unknown.

Methods

In vitro and in vivo experiments have demonstrated the cytotoxic effects of Clo on melanoma and lung cancer. The molecular mechanisms of Clo-induced tumor cell death were analyzed using western blotting, ELISA, reverse transcription-PCR, immunofluorescence, co-immunoprecipitation (CO-IP), short hairpin RNA, co-culture, chromatin immunoprecipitation, and flow cytometry. Clinical data sets were used to analyze the correlation between stimulator of interferon genes (STING)-NFκB signaling and immune infiltration.

Results

In this study, Clo significantly reduced the growth of melanoma and lung cancer cells. Furthermore, Clo treatment induced GSDME-mediated pyroptosis. Most importantly, Clo administration dramatically increased the cytotoxic activity of CD8 + T cells in vitro and in vivo. Mechanistically, the administration of Clo induced the interaction of P53 with STING, which activated the non-canonical STING-NFκB pathway; consequently, NF-κB directly bound to the promoter regions of its target genes, including CCL5, CXCL10, HLAs and BAX. This resulted in apoptosis, pyroptosis, and immunogenic cell death in tumor cells by Clo. Furthermore, Clo-induced GSDME-mediated pyroptosis partly assists in activating T cell immunity via CCL5 and CXCL10. The non-canonical STING-NF-κB pathway is the crucial signaling pathway that initiates and links apoptosis, pyroptosis, and immunogenic cell death.

Conclusions

Our study is the first to show that Clo, an FDA-approved drug, induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8 + T-cell antitumor activity via the non-canonical P53-STING-NF-κB signaling pathway, providing a novel strategy for the clinical therapy of melanoma and lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesTumor Suppressor Protein p53PyroptosisMembrane ProteinsHumansAnimalsMiceSignal TransductionApoptosisCell Line, Tumor

Stichwörter der Autor:innen

Lung CancerMelanoma

Substanzen

Tumor Suppressor Protein p53Membrane ProteinsTP53 protein, human

Autor:innen und Institutionen

  • Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Hunan Key Laboratory of Skin Cancer and Psoriasis, Human Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Furong Laboratory, Central South University, Changsha, Hunan, China.
  • National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China pengcongxy@csu.edu.cn chenxiangck@126.com.

Förderung

  • Natural Science Foundation of Hunan Province
  • 111 Project
  • National Natural Science Foundation of China, Grant

Zitieren

APA

Wu, J., Liu, N., Chen, J., Tao, Q., Lu, C., Li, Q., Chen, X., & Peng, C. (2025). Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8 + T-cell antitumor activity via the non-canonical P53/STING pathway. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2024-010252

Vancouver

Wu J, Liu N, Chen J, Tao Q, Lu C, Li Q, et al. Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8 + T-cell antitumor activity via the non-canonical P53/STING pathway. Journal for ImmunoTherapy of Cancer. 2025. doi:10.1136/jitc-2024-010252

BibTeX
@article{Wu2025,
  author = {Wu, Jie and Liu, Nian and Chen, Jing and Tao, Qian and Lu, Can and Li, Qiuqiu and Chen, Xiang and Peng, Cong},
  title = {Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8 + T-cell antitumor activity via the non-canonical P53/STING pathway},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2025},
  doi = {10.1136/jitc-2024-010252}
}
Kostenlos starten →